Do either of you own. Market cap is $390M after exing out cash vs competitor that just got bought out for $2.7B. The stock has been punished badly from $31 ro $16 over the last 5.5 weeks. According to everything I'm reading RLYPs drug is supposed to be superior to ZS-9, especially for its blood pressure lowering vs ZS-9 which raises BP. I really don't get this stock action yesterday and today being the biotech indexes are staging a rally.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.